Results 11 to 20 of about 24,991 (171)

Prolonged Anhepatic State as a Bridge to Retransplantation: A Challenging Case of a 35-Year-Old Male Liver Transplant Patient with a Temporary Portacaval Shunt. [PDF]

Am J Case Rep, 2023
Patient: Male, 35-year-old Final Diagnosis: Hemorrhagic stroke Symptoms: Coagulopathy • electrolyte disturbances • hypoglycemia • hypotension • hypothermia • metabolic acidosis • renal failure • sepsis Clinical Procedure: — Specialty: Critical Care ...
Araujo Coelho DR, Oliveira da Luz R, Teixeira Basto S, Tavares de Sousa CC, Pereira da Silva H, Martins Fernandes ES, Brito-Azevedo A.   +6 more
europepmc   +2 more sources

Preoperative portal vein recanalization-transjugular intrahepatic portosystemic shunt for chronic obliterative portal vein thrombosis: Outcomes following liver transplantation. [PDF]

Hepatol Commun, 2022
Patients with chronic, obliterative portal vein thrombosis may be converted to liver transplantation candidacy following portal vein recanalization‐transjugular intrahepatic portosystemic shunt (PVR‐TIPS). Long‐term survival outcomes of patients with chronic, obliterative portal vein thrombosis who undergo transplantation following PVR‐TIPS are similar
Talwar A, Varghese J, Knight GM, Katariya N, Caicedo JC, Dietch Z, Borja-Cacho D, Ladner D, Christopher D, Baker T, Abecassis M, Mouli S, Desai K, Riaz A, Thornburg B, Salem R.   +15 more
europepmc   +2 more sources

Coagulation Dysfunction in Patients with Liver Cirrhosis and Splenomegaly and Its Countermeasures: A Retrospective Study of 1522 Patients. [PDF]

Dis Markers, 2023
Objective. Patients with cirrhosis and splenomegaly often have coagulation dysfunction which affects treatment and prognosis. This study explores the status, grading, and treatment strategies of coagulation dysfunction in patients with liver cirrhosis and splenomegaly. Methods.
Lv Y, Liu N, Li Y, Wu J, Zheng J, Li X, Zeng M.   +6 more
europepmc   +2 more sources

Successful surgical manipulation of portacaval shunt in a dog.

The Japanese Journal of Veterinary Science, 1988
Shuichi Koyama, Kunito Kobayashi, Makoto Washizu, Hiromitsu Orima, Noboru Ogi, Takuo Ishida, Shigekatsu Motoyoshi, Tsukimi Washizu   +7 more
openaire   +5 more sources

Techniques for Management of Portal Vein Thrombosis during Liver Transplantation. [PDF]

Case Rep Transplant, 2020
Portal vein thrombosis (PVT) poses a unique challenge in liver transplant. The management of PVT differs according to the extent of thrombosis. Anastomosis of a donor portal vein to a varix is a viable option when an adequate size varix is identified on preoperative imaging or intraoperatively.
Singh N, Washburn K, Black S, Schenk A.
europepmc   +2 more sources

Epidemiology, pathogenesis, diagnosis, surveillance, and management of hepatocellular carcinoma associated with vascular liver disease. [PDF]

Kaohsiung J Med Sci, 2021
Abstract Vascular liver disease (VLD) presents special challenges in the diagnosis, surveillance, and treatment of hepatocellular carcinoma (HCC). HCC arising in the setting of vascular liver disease is often thought to be due to elevated hepatic arterial blood flow, rather than progressive fibrosis from chronic inflammation as with other chronic liver
Prasad D, Nguyen MH.
europepmc   +2 more sources

Liver transplantation in Budd–Chiari patients with history of portacaval shunt surgery

Annaly khirurgicheskoy gepatologii = Annals of HPB surgery, 2023
The paper presents the experience of successful treating a patient with diuretic-resistant ascites associated with Budd– Chiari syndrome. The authors provide a clinical observation of deceased donor liver transplantation to a patient with Budd–Chiari ...
D. A. Altman, A. E. Poltorak, E. A. Kitsenko, B. Sarsenbaev, I. Y. Bondarevsky, A. S. Ryzhikh, A. G. Istomin, T. E. Dorofeeva, M. A. Poltorak, E. M. Khalilov   +9 more
semanticscholar   +1 more source

Glycogen storage disease type I: Genetic etiology, clinical manifestations, and conventional and gene therapies

Pediatric Discovery, Volume 1, Issue 2, September 2023., 2023
Abstract Glycogen storage disease type I (GSDI) is an inherited metabolic disorder characterized by a deficiency of enzymes or proteins involved in glycogenolysis and gluconeogenesis, resulting in excessive intracellular glycogen accumulation. While GSDI is classified into four different subtypes based on molecular genetic variants, GSDIa accounts for ...
Jiamin Zhong, Yannian Gou, Piao Zhao, Xiangyu Dong, Meichun Guo, Aohua Li, Ailing Hao, Hue H. Luu, Tong‐Chuan He, Russell R. Reid, Jiaming Fan   +10 more
wiley   +1 more source

The GABA system, a new target for medications against cognitive impairment—Associated with neuroactive steroids

Journal of Internal Medicine, Volume 294, Issue 3, Page 281-294, September 2023., 2023
Abstract The prevalence of cognitive dysfunction, dementia, and neurodegenerative disorders such as Alzheimer's disease (AD) is increasing in parallel with an aging population. Distinct types of chronic stress are thought to be instrumental in the development of cognitive impairment in central nervous system (CNS) disorders where cognitive impairment ...
Torbjörn Bäckström, Sahruh Turkmen, Roshni Das, Magnus Doverskog, Thomas P. Blackburn   +4 more
wiley   +1 more source

A Challenging Case of Refractory Hepatic Encephalopathy in a Postliver Retransplant Patient with Thrombosed Portal Vein: A Shunt for a Shunt

Case Reports in Hepatology, Volume 2023, Issue 1, 2023., 2023
Hepatic encephalopathy (HE) is a frequent and serious complication of chronic liver disease. The mechanism of hepatic encephalopathy is not entirely clear. Hepatic encephalopathy is defined as brain dysfunction caused by liver insufficiency and/or portal‐systemic blood shunting.
Fady Salama, Anna Christina Leyson, Malay Shah, Roberto Galuppo Monticelli, Sorabh Kapoor   +4 more
wiley   +1 more source